Menu Close

Genetic Engineering Enables Human Immunity to Take on Cancer, Revolutionary Therapy

See on Scoop.itDesign

Medical researchers are using genetic engineering to revolutionise the treatment of cancer.

The way T cell therapy works is that first the cells are taken from a patient’s blood. In the laboratory, they are re-programmed by inserting synthetic genes which make them recognize cancer cells. Finally, these engineered T cells are given back to the patient intravenously. The synthetic genes instruct the T cell to make a so-called ‘chimeric antigen receptor’, a chemical hook that can make the T cell target cancerous cells.

Part of the receptor, projecting from the cell wall, is based on an antibody that can identify a cancer cell. When it encounters such a cell, the receptor activates the T cell, instructing it to attack the cancer, replicate itself and recruit other parts of the immune response to the fight.”

See on www.scienceworldreport.com

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.